Keywords: Actavis, Watson Pharma, M&A rumor, Generic Zomig, Zolmitriptan, Europe, AstraZeneca

Actavis reportedly to be acquired by Watson; debuts generic Zomig

Article | 22 March 2012

Print This

Icelandic generic drugmaker Actavis is said to be in talks to be acquired by US peer Watson Pharmaceuticals (NYSE: WPI) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in